We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Goldman Sachs

News List

EQT Private Equity and Goldman Sachs to acquire Parexel expresspharma
July 05, 2021
Parexel, a global clinical research organisation (CRO), announced the execution of a definitive merger agreement under which it will be acquired by EQT IX fund (EQT Private Equity) and the private equity business within Goldman Sachs Asset Management ...
Puyi Biotechnology Completes Series B Financing prnasia
June 02, 2021
Puyi (Shanghai) Biotechnology Co., Ltd. recently announced the completion of its Series B financing led by Goldman Sachs Asset Management. The proceeds will be used to further augment R&D and business development.
Goldman Sachs invests in Aragen Life Sciences expresspharma
May 20, 2021
Aragen Life Sciences, formerly known as GVK Biosciences announced that Goldman Sachs, an active investor in India, has taken a significant minority stake in the company by acquiring shares previously held by ChrysCapital and other existing shareholders.
Biocon Biologics gets Rs 1, 125 cr capital injection from Goldman Sachs expresspharma
November 09, 2020
Goldman Sachs will be issued Optionally Convertible Debentures at a post money equity valuation of $3.94 billion.